Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZBED10P (Zinc finger BED-type containing 10, pseudogene) is classified by the HUGO Gene Nomenclature Committee (HGNC) as a pseudogene located on human chromosome 7, previously termed C7orf29 and ZBED6CL[4][5]. It is part of the zinc finger BED-type protein family by sequence homology, sharing conserved domains with active ZBED proteins, but is considered non-functional as it does not encode a fully functional protein product. Pseudogenes, like ZBED10P, are remnants of once-functional genes, typically arising via gene duplication or retrotransposition, which have lost protein-coding ability due to frameshifts, early stop codons, or loss of regulatory elements[4][5]. There is no evidence of active translation of ZBED10P or physiological function, nor of any pharmacological or clinical relevance. Although some pseudogenes may regulate other genes at the RNA level, no such activity has been attributed to ZBED10P specifically. It is not considered a specific molecular target in therapeutic contexts.
Not applicable (pseudogene, not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger BED-type containing 10, pseudogene (ZBED10P).